Currently submitted to: JMIR AI
Date Submitted: Oct 9, 2026
Open Peer Review Period: Oct 23, 2026 - Dec 18, 2026
(currently open for review)
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Assessment of pre- and post-treatment multidisciplinary tumour board recommendations with locally-operating 70B Llama-3.3 in HNSCC management
ABSTRACT
Background:
Multidisciplinary tumor boards (MDTs) are essential for personalized treatment planning in head and neck squamous cell carcinoma (HNSCC) but are resource-intensive. Large language models (LLMs) offer potential for clinical decision support, although concerns regarding reliability, patient safety, and data privacy remain.
Objective:
To evaluate the clinical reliability and guideline concordance of a locally deployed, guideline-informed LLM (Llama 3.3, 70B) for the largest real world data set of pre- and posttreatment HNSCC recommendations and investigate the impact of information asymmetry on model performance.
Methods:
This retrospective single-center study included 676 patients with HNSCC, representing 1,127 clinical scenarios (676 pretreatment and 451 posttreatment). All processing by 70b Llama 3.3 was performed locally, ensuring GDPR-compliant data handling. Analysis was guided by structured summaries of international treatment guidelines, to generate pre- and post-therapeutic recommendations. In 676 real patients (1,127 clinical scenarios), LLM outputs were compared with original and simulated MDT decisions to evaluate information bias.
Results:
Concordance with original MDTs was high (pre-therapeutic: 94.8%; post-therapeutic: 91.0%) and further improved in simulated MDT comparisons (97.3% and 96.1%, respectively). Performance was strongest in advanced disease and in distinguishing curative from palliative strategies (accuracy: 97%). Discrepancies were attributable to missing clinical inputs, particularly resectability and ECOG-PS.
Conclusions:
These findings support the use of guideline-informed, locally deployed LLMs as decision-support tools for MDT preparation, while emphasizing the need for supervised implementation and prospective validation.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.